BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 12084982)

  • 1. In vivo fucosylation of lacto-N-neotetraose and lacto-N-neohexaose by heterologous expression of Helicobacter pylori alpha-1,3 fucosyltransferase in engineered Escherichia coli.
    Dumon C; Priem B; Martin SL; Heyraud A; Bosso C; Samain E
    Glycoconj J; 2001 Jun; 18(6):465-74. PubMed ID: 12084982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of the two Helicobacter pylori alpha-1,3-fucosyltransferase ortholog genes for the large-scale synthesis of LewisX human milk oligosaccharides by metabolically engineered Escherichia coli.
    Dumon C; Samain E; Priem B
    Biotechnol Prog; 2004; 20(2):412-9. PubMed ID: 15058985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical characterization of Helicobacter pylori α1-3-fucosyltransferase and its application in the synthesis of fucosylated human milk oligosaccharides.
    Bai J; Wu Z; Sugiarto G; Gadi MR; Yu H; Li Y; Xiao C; Ngo A; Zhao B; Chen X; Guan W
    Carbohydr Res; 2019 Jul; 480():1-6. PubMed ID: 31132553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of 3-Fucosyllactose in Engineered Escherichia coli with α-1,3-Fucosyltransferase from Helicobacter pylori.
    Jung SM; Park YC; Seo JH
    Biotechnol J; 2019 Jun; 14(6):e1800498. PubMed ID: 30927489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation and characterization of linear polylactosamines containing one and two site-specifically positioned Lewis x determinants: WGA agarose chromatography in fractionation of mixtures generated by random, partial enzymatic alpha3-fucosylation of pure polylactosamines.
    Niemelä R; Natunen J; Penttilä L; Salminen H; Helin J; Maaheimo H; Costello CE; Renkonen O
    Glycobiology; 1999 May; 9(5):517-26. PubMed ID: 10207184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a novel alpha1,2-fucosyltransferase of Escherichia coli O128:b12 and functional investigation of its common motif.
    Li M; Liu XW; Shao J; Shen J; Jia Q; Yi W; Song JK; Woodward R; Chow CS; Wang PG
    Biochemistry; 2008 Jan; 47(1):378-87. PubMed ID: 18078329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Whole cell biosynthesis of a functional oligosaccharide, 2'-fucosyllactose, using engineered Escherichia coli.
    Lee WH; Pathanibul P; Quarterman J; Jo JH; Han NS; Miller MJ; Jin YS; Seo JH
    Microb Cell Fact; 2012 Apr; 11():48. PubMed ID: 22545760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzymatic midchain branching of polylactosamine backbones is restricted in a site-specific manner in alpha 1,3-fucosylated chains.
    Leppänen A; Niemelä R; Renkonen O
    Biochemistry; 1997 Nov; 36(44):13729-35. PubMed ID: 9354644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination by electrospray mass spectrometry and 1H-NMR spectroscopy of primary structures of variously fucosylated neutral oligosaccharides based on the iso-lacto-N-octaose core.
    Kogelberg H; Piskarev VE; Zhang Y; Lawson AM; Chai W
    Eur J Biochem; 2004 Mar; 271(6):1172-86. PubMed ID: 15009196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of Escherichia coli strains with chromosomally integrated expression cassettes for the synthesis of 2'-fucosyllactose.
    Baumgärtner F; Seitz L; Sprenger GA; Albermann C
    Microb Cell Fact; 2013 May; 12():40. PubMed ID: 23635327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fucosyltransferases in Schistosoma mansoni development.
    Marques ET; Ichikawa Y; Strand M; August JT; Hart GW; Schnaar RL
    Glycobiology; 2001 Mar; 11(3):249-59. PubMed ID: 11320063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of fucosylated lacto-N-tetraose using whole-cell biotransformation.
    Baumgärtner F; Jurzitza L; Conrad J; Beifuss U; Sprenger GA; Albermann C
    Bioorg Med Chem; 2015 Nov; 23(21):6799-806. PubMed ID: 26481658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Lewis alpha 1-->3/4fucosyltransferase: specificity of fucose transfer to GlcNAc beta 1-->3Gal beta 1-->4Glc beta 1-->1Cer (LcOse3Cer).
    Holmes EH
    Glycobiology; 1993 Feb; 3(1):77-81. PubMed ID: 8448388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering
    Wang L; Zhu Y; Zhao C; Zhao M; Li Z; Xu W; Mu W
    J Agric Food Chem; 2024 May; 72(18):10469-10476. PubMed ID: 38659344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligosaccharides of human milk. Structural studies of two new octasaccharides, difucosyl derivatives of para-lacto-N-hexaose and para-lacto-N-neohexaose.
    Yamashita K; Tachibana Y; Kobata A
    J Biol Chem; 1977 Aug; 252(15):5408-11. PubMed ID: 885859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. H. pylori α1-3/4-fucosyltransferase (Hp3/4FT)-catalyzed one-pot multienzyme (OPME) synthesis of Lewis antigens and human milk fucosides.
    Yu H; Li Y; Wu Z; Li L; Zeng J; Zhao C; Wu Y; Tasnima N; Wang J; Liu H; Gadi MR; Guan W; Wang PG; Chen X
    Chem Commun (Camb); 2017 Oct; 53(80):11012-11015. PubMed ID: 28936496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. O-linked oligosaccharides from salivary agglutinin: Helicobacter pylori binding sialyl-Lewis x and Lewis b are terminating moieties on hyperfucosylated oligo-N-acetyllactosamine.
    Issa S; Moran AP; Ustinov SN; Lin JH; Ligtenberg AJ; Karlsson NG
    Glycobiology; 2010 Aug; 20(8):1046-57. PubMed ID: 20466654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enzymatic synthesis of lacto-N-difucohexaose I which binds to Helicobacter pylori.
    Miyazaki T; Sato T; Furukawa K; Ajisaka K
    Methods Enzymol; 2010; 480():511-24. PubMed ID: 20816225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification of the Lewis blood-group gene associated alpha-3/4-fucosyltransferase from human milk: an enzyme transferring fucose primarily to type 1 and lactose-based oligosaccharide chains.
    Johnson PH; Watkins WM
    Glycoconj J; 1992 Oct; 9(5):241-9. PubMed ID: 1490103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced production of 2'-fucosyllactose in engineered Escherichia coli BL21star(DE3) by modulation of lactose metabolism and fucosyltransferase.
    Chin YW; Kim JY; Lee WH; Seo JH
    J Biotechnol; 2015 Sep; 210():107-15. PubMed ID: 26193630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.